Sustainability of remission of pediatric primary nocturnal enuresis--comparison of remission using Try for Dry vs. non-Try for Dry treatment plans.
This study examined the sustainability of remission of primary nocturnal enuresis (PNE) using an algorithm-based multimodal treatment plan, Try for Dry. Remission of PNE using the Try for Dry treatment method was retained longer and more often than using a non-Try for Dry plan.
Saldano
Dawn Diaz
DD
Division of Urology, Children's Memorial Hospital, Chicago, IL, USA.
Chaviano
Antonio H
AH
Maizels
Max
M
D000293:Adolescent; D000465:Algorithms; D050034:Antidiuretic Agents / Q000627:therapeutic use; D002648:Child; D003131:Combined Modality Therapy; D003248:Constipation / Q000209:etiology / Q000517:prevention & control; D003894:Deamino Arginine Vasopressin / Q000627:therapeutic use; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D004868:Equipment Failure; D006801:Humans; D015994:Incidence; D053208:Kaplan-Meier Estimate; D008333:Mandelic Acids / Q000627:therapeutic use; D018727:Muscarinic Antagonists / Q000627:therapeutic use; D053206:Nocturnal Enuresis / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control*; D015403:Nursing Evaluation Research; D010347:Patient Care Planning / Q000458:organization & administration*; D012074:Remission Induction; D012189:Retrospective Studies; D011795:Surveys and Questionnaires; D014039:Toilet Training; D016896:Treatment Outcome; D014563:Urodynamics
D050034:Antidiuretic Agents; D008333:Mandelic Acids; D018727:Muscarinic Antagonists; D003894:Deamino Arginine Vasopressin; C005419:oxybutynin